Correlation Between CHC Healthcare and ScinoPharm Taiwan

Can any of the company-specific risk be diversified away by investing in both CHC Healthcare and ScinoPharm Taiwan at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CHC Healthcare and ScinoPharm Taiwan into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CHC Healthcare Group and ScinoPharm Taiwan, you can compare the effects of market volatilities on CHC Healthcare and ScinoPharm Taiwan and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CHC Healthcare with a short position of ScinoPharm Taiwan. Check out your portfolio center. Please also check ongoing floating volatility patterns of CHC Healthcare and ScinoPharm Taiwan.

Diversification Opportunities for CHC Healthcare and ScinoPharm Taiwan

0.71

Correlation Coefficient

CHC Healthcare  ScinoPharm Taiwan

Poor diversification

The 3 months correlation between CHC and ScinoPharm is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding CHC Healthcare Group and ScinoPharm Taiwan in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ScinoPharm Taiwan and CHC Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CHC Healthcare Group are associated (or correlated) with ScinoPharm Taiwan. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ScinoPharm Taiwan has no effect on the direction of CHC Healthcare i.e., CHC Healthcare and ScinoPharm Taiwan go up and down completely randomly.

Pair Corralation between CHC Healthcare and ScinoPharm Taiwan

Assuming the 90 days trading horizon CHC Healthcare Group is expected to generate 2.14 times more return on investment than ScinoPharm Taiwan. However, CHC Healthcare is 2.14 times more volatile than ScinoPharm Taiwan. It trades about -0.04 of its potential returns per unit of risk. ScinoPharm Taiwan is currently generating about -0.25 per unit of risk. If you would invest  4,305  in CHC Healthcare Group on September 25, 2024 and sell it today you would lose (240.00) from holding CHC Healthcare Group or give up 5.57% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

CHC Healthcare Group  vs.  ScinoPharm Taiwan

CHC Healthcare Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CHC Healthcare Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, CHC Healthcare is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

ScinoPharm Taiwan

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ScinoPharm Taiwan has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with CHC Healthcare and ScinoPharm Taiwan

The main advantage of trading using opposite CHC Healthcare and ScinoPharm Taiwan positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CHC Healthcare position performs unexpectedly, ScinoPharm Taiwan can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ScinoPharm Taiwan will offset losses from the drop in ScinoPharm Taiwan's long position.

The idea behind CHC Healthcare Group and ScinoPharm Taiwan pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.